Allele, SCM Lifescience sign joint research and development agreement to develop iPSC-based diabetes treatment

Image: Allele, SCM Lifescience sign joint research and development agreement to develop iPSC-based diabetes treatment. Photo: courtesy of Tumisu/Pixabay.